Cargando…
Chromogranin-A Expression as a Novel Biomarker for Early Diagnosis of Colon Cancer Patients
Colon cancer is one of the major causes of cancer death worldwide. The five-year survival rate for the early-stage patients is more than 90%, and only around 10% for the later stages. Moreover, half of the colon cancer patients have been clinically diagnosed at the later stages. It is; therefore, of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628020/ https://www.ncbi.nlm.nih.gov/pubmed/31207989 http://dx.doi.org/10.3390/ijms20122919 |